These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26505861)

  • 1. Marked Response to 177Lu Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer.
    Soydal C; Ozkan E; Akyurek S; Kucuk NO
    Clin Nucl Med; 2016 Feb; 41(2):159-60. PubMed ID: 26505861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy.
    Vadi SK; Kumar R; Mittal BR; Parihar AS; Singh SK
    Clin Nucl Med; 2018 Apr; 43(4):276-278. PubMed ID: 29465493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of post-therapy
    Tuncel M; Telli T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):114-117. PubMed ID: 28750750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
    Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B
    Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT.
    Lawal I; Vorster M; Boshomane T; Ololade K; Ebenhan T; Sathekge M
    Clin Nucl Med; 2015 Sep; 40(9):755-6. PubMed ID: 26053729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Body Integrated [
    Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
    Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis.
    Kobe C; Maintz D; Fischer T; Drzezga A; Chang DH
    Clin Nucl Med; 2015 Nov; 40(11):897-8. PubMed ID: 26018688
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    van Boxtel W; Lütje S; van Engen-van Grunsven ICH; Verhaegh GW; Schalken JA; Jonker MA; Nagarajah J; Gotthardt M; van Herpen CML
    Theranostics; 2020; 10(5):2273-2283. PubMed ID: 32089741
    [No Abstract]   [Full Text] [Related]  

  • 9. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
    Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
    Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.
    Baum RP; Kulkarni HR; Schuchardt C; Singh A; Wirtz M; Wiessalla S; Schottelius M; Mueller D; Klette I; Wester HJ
    J Nucl Med; 2016 Jul; 57(7):1006-13. PubMed ID: 26795286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.
    Kratochwil C; Giesel FL; Eder M; Afshar-Oromieh A; Benešová M; Mier W; Kopka K; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):987-8. PubMed ID: 25573634
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT.
    Chakraborty PS; Tripathi M; Agarwal KK; Kumar R; Vijay MK; Bal C
    Clin Nucl Med; 2015 Feb; 40(2):e163-6. PubMed ID: 25275415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients.
    Sterzing F; Kratochwil C; Fiedler H; Katayama S; Habl G; Kopka K; Afshar-Oromieh A; Debus J; Haberkorn U; Giesel FL
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):34-41. PubMed ID: 26404016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
    Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
    J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
    Afshar-Oromieh A; Avtzi E; Giesel FL; Holland-Letz T; Linhart HG; Eder M; Eisenhut M; Boxler S; Hadaschik BA; Kratochwil C; Weichert W; Kopka K; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):197-209. PubMed ID: 25411132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
    J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study between
    Wong HS; Leung J; Bartholomeusz D; Sutherland P; Le H; Nottage M; Iankov I; Chang JH
    J Med Imaging Radiat Oncol; 2018 Dec; 62(6):816-822. PubMed ID: 30152050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Utility of Lutetium-177 (Lu 177) Prostate-Specific Membrane Antigen (PSMA) Scintigraphy In Prostate Cancer Patients With PSA Rise And Negative Conventional Imaging.
    Ghodsirad MA; Pirayesh E; Akbarian R; Javanmard B; Kaghazchi F; Tavakoli M; Fattahi K
    Urol J; 2020 Jun; 17(4):374-378. PubMed ID: 32281092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
    Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
    Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients.
    Onal C; Torun N; Akyol F; Guler OC; Hurmuz P; Yildirim BA; Cağlar M; Reyhan M; Ozyigit G
    Clin Nucl Med; 2019 Sep; 44(9):e510-e516. PubMed ID: 31283600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.